Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2015 Mar 1;25(5):998-1008. doi: 10.1016/j.bmcl.2014.12.076. Epub 2015 Jan 12.

Target engagement in lead generation.

Author information

1
Discovery Chemistry Research and Technologies, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285, USA.

Abstract

The pharmaceutical industry is currently facing multiple challenges, in particular the low number of new drug approvals in spite of the high level of R&D investment. In order to improve target selection and assess properly the clinical hypothesis, it is important to start building an integrated drug discovery approach during Lead Generation. This should include special emphasis on evaluating target engagement in the target tissue and linking preclinical to clinical readouts. In this review, we would like to illustrate several strategies and technologies for assessing target engagement and the value of its application to medicinal chemistry efforts.

KEYWORDS:

Bioluminescent imaging (BLI); Biomarker; Cellular thermal shift assay (CETSA); Lead Generation; Positron emission tomography (PET); Receptor occupancy (RO); Target engagement

PMID:
25630223
DOI:
10.1016/j.bmcl.2014.12.076
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center